
A conceptual illustration of insulin vials, symbolising China’s plan to build Africa’s first local insulin production facility in Nigeria. (Image credit: Internet)
ABUJA, Nigeria – China has announced plans to establish Africa’s first local insulin production facility in Nigeria, a move expected to reduce the country’s reliance on imported medication and strengthen its healthcare sector.
Speaking on Wednesday at a reception in Abuja to mark the 76th anniversary of the founding of the People’s Republic of China, Ambassador Yu Dunhai said Chinese companies are in advanced discussions with Nigerian authorities on the project.
“The facility will end Nigeria’s dependence on imported insulin and position the country as a hub for African medical biotechnology,” Dunhai stated. He described the initiative as part of China’s commitment to expanding its “comprehensive strategic partnership” with Nigeria.
The envoy highlighted health as a priority in bilateral cooperation, alongside infrastructure and trade.
He also praised Nigeria for endorsing China’s Global Governance Initiative, saying the partnership reflects mutual respect and shared development goals.
Analysts say the planned facility could transform diabetes care in Nigeria, where access to affordable insulin remains a major challenge. According to the International Diabetes Federation, more than 3 million Nigerians are currently living with diabetes, with many struggling to afford regular treatment.
Deputy Senate President Barau Jibrin, represented by Senator Babangida Hussaini, welcomed the announcement, saying it underscores the growing value of Chinese investment in Nigeria’s economy and healthcare.
“This project is not only about medicine, but also about saving lives and building Nigeria’s capacity to serve Africa,” Jibrin said.